Literature DB >> 32675210

Characteristics and outcomes of health and social care workers testing positive for SARS-CoV-2 in the Tayside region of Scotland.

Moneeza K Siddiqui1, Benjamin Parcell2, Sarah Allstaff3, Colin Palmer1, James D Chalmers4, Samira Bell1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32675210      PMCID: PMC7366178          DOI: 10.1183/13993003.02568-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
To the Editor: The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and reported outcomes among health and social care workers (HSCWs) is concerning [1-3]. Early in the outbreak it was recommended in the UK that HSCWs experiencing symptoms of a cough or fever remain absent from work for 7 days. In order to address this problem, National Health Service (NHS) Tayside, a health board in Scotland covering a population of 400,000, was the first in Scotland to set up a drive-through testing programme for HSCWs, other key workers and their symptomatic household contacts (including children), with results available within 24 h, allowing staff to return to work following a negative test [4]. As testing for SARS-CoV-2 was limited to hospitalised patients across much of Europe there is limited data on the self-reported clinical characteristics and outcomes of patients in the community with coronavirus disease 2019 (COVID-19). Here, we report characteristics and outcomes of HSCWs presenting to the drive-through testing centre who tested positive for SARS-CoV-2 on a combined nasal and pharyngeal swab. Anonymised record linkage was conducted between routinely collected healthcare datasets in order to ascertain clinical characteristics and outcomes of those who tested positive. All hospitalisations until 25 April and deaths until 20 May, 2020 were recorded. Approval was obtained from the local data protection officer (Caldicott Guardian). Between 17 March, 2020 and the 27 April, 2020, 2993 symptomatic HSCWs in NHS Tayside were tested for SARS-CoV-2 through the drive-through facility with 677 (22.6%) of these testing positive (figure 1). Of those who tested positive, 45% presented with a fever, 70% a cough and 9% experienced shortness of breath. 32% reported both a fever and cough. Mean±sd age of those who tested positive was 44.7±20) and 77% were female. Overall, the burden of comorbidity was low in this group: 3.7% had diabetes; 2.2% had COPD; 5.9% had ischaemic heart disease; nobody had chronic kidney disease; 5.9% had been treated with lipid lowering treatment and 25% anti-hypertensive medications.
FIGURE 1

Proportion of positive tests in health and social care workers in Tayside, Scotland. Percent positive for week 2–7 were 17%, 27%, 28%, 29%, 18% and 14% respectively. There were no recorded positive tests in the first week of testing.

Proportion of positive tests in health and social care workers in Tayside, Scotland. Percent positive for week 2–7 were 17%, 27%, 28%, 29%, 18% and 14% respectively. There were no recorded positive tests in the first week of testing. Hospitalisations were recorded using the new ICD code for COVID-19: U07.1 [5] Eight individuals were hospitalised (the majority of which were for 24 h or less). The average time between a positive PCR test and hospitalisation was 4 days for males and 7 for females. There were fewer than five deaths (number suppressed due to potential identifiable disclosure). We did not have access to data on ethnicity, but the population covered by NHS Tayside is 99% white ethnicity with 97% of NHS Tayside staff workers recorded as being of white ethnicity in 2019. We have found that in a predominately low comorbid white population of symptomatic HSCWs self-presenting to a drive through testing facility, there was a relatively high prevalence of SARS-CoV-2. However, this was associated with mild disease in the majority of cases. Not only does this approach to staff testing minimise workforce depletion, but also, no doubt plays a role in reducing transmission of SARS-CoV-2 in hospitals and care facilities [6]. This one-page PDF can be shared freely online. Shareable PDF ERJ-02568-2020.Shareable
  4 in total

1.  COVID-19: protecting health-care workers.

Authors: 
Journal:  Lancet       Date:  2020-03-21       Impact factor: 79.321

2.  COVID-19: the case for health-care worker screening to prevent hospital transmission.

Authors:  James R M Black; Chris Bailey; Joanna Przewrocka; Krijn K Dijkstra; Charles Swanton
Journal:  Lancet       Date:  2020-04-16       Impact factor: 79.321

3.  COVID-19: how prepared are front-line healthcare workers in England?

Authors:  K Prescott; E Baxter; C Lynch; S Jassal; A Bashir; J Gray
Journal:  J Hosp Infect       Date:  2020-04-24       Impact factor: 3.926

Review 4.  Drive-through testing for SARS-CoV-2 in symptomatic health and social care workers and household members: an observational cohort study.

Authors:  Benjamin J Parcell; Kathryn Brechin; Sarah Allstaff; Meg Park; Wendy Third; Susan Bean; Chris Hind; Rajiv Farmer; Daniel Chandler; James D Chalmers
Journal:  Thorax       Date:  2020-08-27       Impact factor: 9.139

  4 in total
  4 in total

1.  Requirement of a prompt solution to address infection and mortality due to COVID-19 among Peruvian physicians.

Authors:  Marcio José Concepción-Zavaleta; Diego Moreno Marreros; Julia Cristina Coronado Arroyo; Luis Alberto Concepción Urteaga; Francisca Elena Zavaleta Gutiérrez
Journal:  J Public Health (Oxf)       Date:  2021-06-07       Impact factor: 2.341

2.  Healthcare Workers' Knowledge, Attitude, and Practice Regarding Personal Protective Equipment for the Prevention of COVID-19.

Authors:  Mohammad Ali Hossain; Md Utba Bin Rashid; Md Abdullah Saeed Khan; Sabrina Sayeed; Md Abdul Kader; Mohammad Delwer Hossain Hawlader
Journal:  J Multidiscip Healthc       Date:  2021-02-02

3.  Pandemic trials: evidence-based medicine on steroids.

Authors:  James D Chalmers
Journal:  Eur Respir J       Date:  2020-12-24       Impact factor: 16.671

4.  Healthcare workers with COVID-19 in Mexico.

Authors:  Silvio A Ñamendys-Silva
Journal:  Eur Respir J       Date:  2020-10-01       Impact factor: 16.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.